These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9552394)

  • 1. Cellular responses to antimetabolite anticancer agents: cytostasis versus cytotoxicity.
    Houghton JA; Houghton PJ
    Prog Cell Cycle Res; 1996; 2():175-85. PubMed ID: 9552394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical and molecular effects of UCN-01 in combination with 5-fluorodeoxyuridine in A431 human epidermoid cancer cells.
    Grem JL; Danenberg KD; Kao V; Danenberg PV; Nguyen D
    Anticancer Drugs; 2002 Mar; 13(3):259-70. PubMed ID: 11984070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell death in response to antimetabolites directed at thymidylate synthase.
    Barbour KW; Berger FG
    Cancer Chemother Pharmacol; 2008 Feb; 61(2):189-201. PubMed ID: 17396263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of folate metabolism: features relevant to the action and toxicities of antifolate anticancer agents.
    Calvert H
    Semin Oncol; 1999 Apr; 26(2 Suppl 6):3-10. PubMed ID: 10598549
    [No Abstract]   [Full Text] [Related]  

  • 5. Cell cycle control processes determine cytostasis or cytotoxicity in thymineless death of colon cancer cells.
    Houghton JA; Harwood FG; Houghton PJ
    Cancer Res; 1994 Sep; 54(18):4967-73. PubMed ID: 8069864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymineless death in colon carcinoma cells is mediated via fas signaling.
    Houghton JA; Harwood FG; Tillman DM
    Proc Natl Acad Sci U S A; 1997 Jul; 94(15):8144-9. PubMed ID: 9223329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymidylate synthase inhibition triggers glucose-dependent apoptosis in p53-negative leukemic cells.
    Muñoz-Pinedo C; Robledo G; López-Rivas A
    FEBS Lett; 2004 Jul; 570(1-3):205-10. PubMed ID: 15251465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular pharmacology of MTA: a correlation of MTA-induced cellular toxicity and in vitro enzyme inhibition with its effect on intracellular folate and nucleoside triphosphate pools in CCRF-CEM cells.
    Chen VJ; Bewley JR; Andis SL; Schultz RM; Iversen PW; Shih C; Mendelsohn LG; Seitz DE; Tonkinson JL
    Semin Oncol; 1999 Apr; 26(2 Suppl 6):48-54. PubMed ID: 10598555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymidylate synthase as a target in cancer chemotherapy.
    Peters GJ; van der Wilt CL
    Biochem Soc Trans; 1995 Nov; 23(4):884-8. PubMed ID: 8654859
    [No Abstract]   [Full Text] [Related]  

  • 10. Ratio of 2'-deoxyadenosine-5'-triphosphate/thymidine-5'-triphosphate influences the commitment of human colon carcinoma cells to thymineless death.
    Houghton JA; Tillman DM; Harwood FG
    Clin Cancer Res; 1995 Jul; 1(7):723-30. PubMed ID: 9816038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serine/threonine protein phosphatase inhibition enhances the effect of thymidylate synthase inhibition.
    Sakoff JA; Howitt IJ; Ackland SP; McCluskey A
    Cancer Chemother Pharmacol; 2004 Mar; 53(3):225-32. PubMed ID: 14648018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymidylate synthase as a chemotherapeutic drug target: where are we after fifty years?
    Berger FG; Berger SH
    Cancer Biol Ther; 2006 Sep; 5(9):1238-41. PubMed ID: 17035726
    [No Abstract]   [Full Text] [Related]  

  • 13. DNA damage and p53 induction do not cause ZD1694-induced cell cycle arrest in human colon carcinoma cells.
    Matsui SI; Arredondo MA; Wrzosek C; Rustum YM
    Cancer Res; 1996 Oct; 56(20):4715-23. PubMed ID: 8840989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.
    Taddia L; D'Arca D; Ferrari S; Marraccini C; Severi L; Ponterini G; Assaraf YG; Marverti G; Costi MP
    Drug Resist Updat; 2015 Nov; 23():20-54. PubMed ID: 26690339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of anti-metabolite effects. Effects of thymidine on the efficacy of the quinazoline-based thymidylate synthetase inhibitor, CB3717.
    Jackman AL; Taylor GA; Calvert AH; Harrap KR
    Biochem Pharmacol; 1984 Oct; 33(20):3269-75. PubMed ID: 6487375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Thymidylate Synthase Inhibitors Halting Ovarian Cancer Growth.
    Ferrari S; Severi L; Pozzi C; Quotadamo A; Ponterini G; Losi L; Marverti G; Costi MP
    Vitam Horm; 2018; 107():473-513. PubMed ID: 29544641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of uracil DNA glycosylase (UDG) does not affect cellular sensitivity to thymidylate synthase (TS) inhibition.
    Welsh SJ; Hobbs S; Aherne GW
    Eur J Cancer; 2003 Feb; 39(3):378-87. PubMed ID: 12565992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrasting patterns of DNA fragmentation induced by thymidylate synthase inhibitors, ZD1694 and AG-331.
    Panadero A; Yin MB; Voigt W; Rustum YM
    Oncol Res; 1995; 7(2):73-81. PubMed ID: 7579730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of both endogenous folates and thymidine enhance the therapeutic efficacy of thymidylate synthase inhibitors.
    van der Wilt CL; Backus HH; Smid K; Comijn L; Veerman G; Wouters D; Voorn DA; Priest DG; Bunni MA; Mitchell F; Jackman AL; Jansen G; Peters GJ
    Cancer Res; 2001 May; 61(9):3675-81. PubMed ID: 11325838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic and biochemical implications of combining AZT and AG-331.
    Pressacco J; Mitrovski B; Erlichman C
    Cancer Chemother Pharmacol; 1995; 35(5):387-90. PubMed ID: 7850919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.